Stock KYTX KYVERNA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Kyverna Therapeutics, Inc.

Equities

KYTX

US5019761049

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-31 EDT 		5-day change 1st Jan Change
12.53 USD +1.70% Intraday chart for Kyverna Therapeutics, Inc. -3.62% -.--%
05-14 Kyverna Therapeutics Q1 Loss Narrows MT
05-14 Kyverna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Kyverna Therapeutics Q1 Loss Narrows
MT
Kyverna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Nasdaq's revenue beats on strong demand for fintech products
RE
Kyverna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kyverna Therapeutics Teams Up With Stanford University to Evaluate Investigational Multiple Sclerosis Drug
MT
Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis
CI
Kyverna Therapeutics Closes $366.9 Million Initial Public Offering
MT
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KYTX Stock
  4. News Kyverna Therapeutics, Inc.
  5. Highlights